Alopecia Areata Treatment London 2026: The Doctor-Led JAK Inhibitor and Regenerative Pathway

By the medical team at The London PRP Clinic by The Wellness. Last reviewed April 2026. GMC-registered doctors. Marylebone (2 minutes from Baker Street).

At a glance

Alopecia areata affects approximately 2% of the global population at some point in life, with the UK National Alopecia Areata Foundation estimating 147,000+ people currently affected in the UK. Modern treatment in 2026 has been transformed by the MHRA approval and NICE recommendation of two JAK inhibitor drugs, baricitinib (Olumiant) and ritlecitinib (Litfulo), which deliver SALT score 50% improvement in approximately 35-40% of patients with severe disease. At The London PRP Clinic by The Wellness, the alopecia areata pathway combines structured medical assessment (£445 comprehensive consultation including diagnostic blood panel), MHRA-licensed treatments where appropriate, and adjunctive regenerative therapy including PRP from £545 and ExoRevive exosome therapy from £445 for stable-phase disease. Pricing aligns with London's leading dermatology and trichology specialists including Dr Haus Dermatology on Harley Street, the Harley Street Dermatology Clinic, the London Skin and Hair Clinic, and the specialist alopecia services at Wimpole Her. Every treatment is delivered by GMC-registered doctors with structured integration to The Wellness primary care services for autoimmune workup and broader systemic assessment.

The reason alopecia areata treatment has been so historically frustrating is that the condition is autoimmune, the existing therapies (topical steroids, intralesional steroid injection, contact immunotherapy, immunosuppressants) had inconsistent efficacy and meaningful side effects, and many patients cycled through treatments without sustained benefit. The 2022 MHRA approval of baricitinib and 2024 NICE technology appraisal recommending ritlecitinib changed this fundamentally. For the first time, severe alopecia areata has evidence-based licensed treatment with documented efficacy. The London PRP Clinic by The Wellness offers integrated assessment for these treatments alongside our regenerative therapy portfolio, providing the comprehensive alopecia areata pathway that most aesthetic clinics cannot match.

Message us on WhatsApp for fastest response

Email: team@thewellnesslondon.com

Phone: 020 3951 3429

What is alopecia areata and how is it different from other hair loss?

Alopecia areata is an autoimmune condition where the immune system mistakenly attacks hair follicles, causing non-scarring hair loss. The hair follicle infrastructure is preserved, which is why hair regrowth is biologically possible even after extensive hair loss. The condition affects approximately 2% of the population at some point in life, can begin at any age but most commonly first appears between ages 10 and 40, and shows no significant gender preference.

The published clinical literature including the British Association of Dermatologists 2024 guidance on alopecia areata, the Journal of Investigative Dermatology systematic reviews, the New England Journal of Medicine pivotal trials, and the Lancet reviews recognise three primary patterns of presentation.

Patchy alopecia areata is the most common pattern. Discrete circular or oval bald patches, typically the size of a coin, on the scalp or other body areas. Patches can be isolated (single) or multiple. The pattern can spontaneously remit, persist, or progress to more extensive forms.

Alopecia totalis is complete or near-complete loss of scalp hair. This represents disease progression in patients who initially had patchy disease, or can present de novo.

Alopecia universalis is the most severe form, with complete loss of scalp hair, eyebrows, eyelashes, and body hair. Approximately 5% of alopecia areata patients progress to this form.

Variants include ophiasis pattern (hair loss along the hairline at the back and sides of the scalp), sisaipho pattern (the reverse, with hair loss in the central scalp sparing the periphery), and diffuse alopecia areata (rapid diffuse thinning resembling telogen effluvium but with the underlying autoimmune mechanism).

How alopecia areata differs from female pattern hair loss. Female pattern hair loss is genetic and androgen-driven, with diffuse thinning across the crown without complete bald patches. Alopecia areata is autoimmune-driven with discrete patches or rapid onset. The treatments are completely different. The diagnostic distinction is critical and is established at trichoscopic examination plus medical history.

How alopecia areata differs from telogen effluvium. Telogen effluvium is reactive shedding triggered by physiological stress (illness, postpartum, severe stress, rapid weight loss, medication change). The pattern is diffuse, the trigger is identifiable, and recovery typically follows trigger resolution. Alopecia areata can sometimes present diffusely (mimicking telogen effluvium) and the distinction requires careful clinical assessment.

How alopecia areata differs from scarring alopecia. Scarring alopecias (frontal fibrosing alopecia, lichen planopilaris, central centrifugal cicatricial alopecia) destroy the hair follicle infrastructure, making hair regrowth impossible without surgical intervention. Alopecia areata preserves the follicles, which is why aggressive treatment can deliver complete regrowth.

What treatments are available for alopecia areata at The London PRP Clinic by The Wellness?

The treatment landscape transformed dramatically with the introduction of JAK inhibitors. The current evidence-based options in 2026 are as follows.

JAK inhibitors (oral systemic therapy) are the breakthrough treatment for severe alopecia areata. Baricitinib (Olumiant, by Lilly) is licensed in the UK and recommended by NICE for severe alopecia areata in adults with SALT score 50 or higher. The published BRAVE-AA1 and BRAVE-AA2 phase 3 trials in the New England Journal of Medicine showed approximately 35-40% of patients achieved SALT score 20 or below at 36 weeks, representing 80%+ scalp coverage. Ritlecitinib (Litfulo, by Pfizer) is licensed in the UK and recommended by NICE for severe alopecia areata in patients aged 12 and over. The ALLEGRO phase 2b/3 trial showed comparable efficacy to baricitinib with the additional advantage of paediatric and adolescent licensing. Both medications require comprehensive baseline screening (full blood count, TB screening, hepatitis serology, lipid profile) and ongoing monitoring per the MHRA class-level safety guidance addressing serious infection, major cardiovascular events, venous thromboembolism, and malignancy risks.

Intralesional steroid injection (triamcinolone acetonide). The traditional first-line treatment for limited patchy alopecia areata. We deliver structured intralesional steroid protocols with appropriate dosing and follow-up. Effective for individual patches but not for extensive disease.

Topical steroid therapy. Potent topical steroids applied to affected patches. Useful for limited disease and as adjunct to other treatments.

Topical minoxidil. Used as adjunct therapy to support regrowth following the autoimmune flare resolution.

Contact immunotherapy (diphenylcyclopropenone, DPCP). Specialist-only treatment applied at a dedicated dermatology service. We refer to specialist partners where indicated.

Methotrexate, ciclosporin, and other immunosuppressants. Off-label systemic treatments used in selected severe cases pre-JAK inhibitor era. Now generally superseded by JAK inhibitors except in patients with contraindications.

PRP scalp therapy. Particularly useful in stable-phase alopecia areata or as adjunct to systemic therapy during the regrowth phase. The published evidence in the Journal of Cosmetic Dermatology supports PRP for selected alopecia areata cases. Single session £545, course of three £1,455.

ExoRevive exosome therapy. Emerging evidence for stable-phase alopecia areata. Single session £445, combined with PRP £500. Useful where standard regenerative therapy has been insufficient.

Polynucleotide scalp injection. Emerging evidence for adjunctive use. Single session £445, combined with PRP £595.

Hair transplantation. Generally not recommended for active alopecia areata because the autoimmune process can attack transplanted follicles. Only considered in stable burnout cases with appropriate specialist assessment.

Camouflage and supportive interventions. Scalp prosthetics, wigs, micropigmentation, microblading for eyebrow loss, and false eyelashes for eyelash loss are integrated into the broader supportive pathway where appropriate.

Psychological support. Alopecia areata has profound psychosocial impact. We integrate referral to specialist psychological services and signpost the UK alopecia patient organisations including Alopecia UK.

What is the diagnostic and treatment pathway at The London PRP Clinic by The Wellness?

The structured pathway includes the following stages.

Stage one: comprehensive consultation (£445). 30-minute consultation with a GMC-registered doctor covering detailed medical history including hair loss timeline, family history of autoimmune conditions, personal history of autoimmune conditions, medication review, psychosocial impact assessment, focused examination including scalp, eyebrows, eyelashes, body hair, nail examination (alopecia areata can affect nails with pitting and ridging), and trichoscopic scalp examination revealing the characteristic exclamation mark hairs, yellow dots, and black dots that confirm alopecia areata diagnosis.

Stage two: SALT scoring. The Severity of Alopecia Tool quantifies the percentage of scalp hair loss and is the validated measure used in clinical trials and treatment guidelines. SALT score 0-20 = mild, 21-49 = moderate, 50-94 = severe, 95-100 = very severe. Treatment selection follows from the SALT score and disease pattern.

Stage three: comprehensive blood panel. Included in the £445 package. Covers full blood count, TSH plus free T4 plus anti-thyroid antibodies (alopecia areata frequently associates with autoimmune thyroid disease), vitamin D, vitamin B12, ferritin, iron studies, ANA and other autoimmune markers where indicated, baseline screening for JAK inhibitor candidates including hepatitis B and C serology, HIV (for treatment-naive patients considering systemic therapy), and lipid profile.

Stage four: structured diagnosis and treatment plan. With complete diagnostic picture, your doctor explains the SALT score, the pattern, the prognosis based on duration and severity, and the personalised treatment recommendations. Severe disease (SALT 50+) is assessed for JAK inhibitor candidacy. Mild-to-moderate patchy disease is treated with intralesional steroids and topical therapy. PRP and regenerative options are integrated for stable-phase patients seeking adjunctive support.

Stage five: structured treatment delivery and monitoring. JAK inhibitor candidates receive baseline screening and ongoing monitoring per MHRA guidance. Intralesional steroid injections delivered in clinic at structured intervals. PRP and regenerative therapy delivered per standard protocols with photographic outcome tracking.

Stage six: longitudinal follow-up. Alopecia areata is a chronic relapsing condition. We maintain longitudinal follow-up including SALT score tracking, photographic documentation, treatment adjustment, and integration with broader autoimmune health management.

WhatsApp the team to discuss your alopecia areata

What is the pricing structure at The London PRP Clinic by The Wellness?

Comprehensive Alopecia Areata Initial Consultation Package: £445. Including the 30-minute consultation, comprehensive medical history, SALT score documentation, focused examination, trichoscopic scalp examination, comprehensive blood panel covering autoimmune and metabolic markers, and structured diagnosis with treatment plan.

Intralesional steroid injection (per session, single area): £295. Including triamcinolone acetonide injection at appropriate concentration, structured aftercare, and follow-up.

Intralesional steroid injection (per session, multi-area): £445.

Single PRP scalp session: £545.

Course of three PRP scalp sessions: £1,455.

Combined PRP plus ExoRevive scalp session: £500. Course of three: £1,895.

Combined PRP plus polynucleotide scalp session: £595. Course of three: £1,795.

Comprehensive triple regenerative scalp session (PRP plus ExoRevive plus polynucleotide): £795. Course of three: £2,395.

JAK inhibitor pathway. The medications themselves (baricitinib, ritlecitinib) are MHRA-licensed and where eligible, can be accessed via NHS specialist dermatology referral. We facilitate this referral pathway where indicated. Private prescription pathway with comprehensive baseline screening, structured monitoring, and medication supply available where patients prefer private route. Pricing for private JAK inhibitor pathway: £495 specialist consultation including baseline screening review, plus medication cost (varies by drug and dose) plus £295 quarterly monitoring review.

Specialist dermatology referral. Where complex disease, scarring suspicion, or specialist intervention required. We refer to appropriate consultant dermatology partners.

How this anchors against the London market in 2026. Dr Haus Dermatology on Harley Street, the Harley Street Dermatology Clinic, the London Dermatology Centre, and the London Skin and Hair Clinic offer specialist consultant-led alopecia areata pathways with consultation fees from £250-£450 plus additional treatment costs. Wimpole Her offers comprehensive women's alopecia pathway with PRP £295-£850 and dedicated diagnostic protocols. Rejuvence Clinic offers alopecia areata pathway integrating regenerative options. We sit firmly in the heart of the doctor-led premium tier with pricing that reflects the comprehensive blood panel included in the consultation package, the integrated regenerative options, and the structured monitoring pathway.

We do not undercut London's leading alopecia clinics. We are a peer to them. The combination of doctor-led delivery, structured comprehensive blood panel within the consultation package, integrated regenerative options, and accessible JAK inhibitor pathway through specialist referral or private prescribing positions us at the top of the doctor-led alopecia areata tier in London 2026.

Why does The London PRP Clinic by The Wellness deliver better outcomes for alopecia areata than most clinics?

There are five reasons our alopecia areata outcomes consistently exceed the typical clinic offering.

First, comprehensive diagnostic protocol within the initial package. The £445 consultation includes the comprehensive blood panel that most clinics charge separately. The autoimmune workup, thyroid assessment, vitamin status, and baseline JAK inhibitor screening are all integrated. The patient receives the full diagnostic picture at the first appointment rather than over multiple visits.

Second, integrated JAK inhibitor pathway. Most aesthetic clinics do not offer access to baricitinib or ritlecitinib. Most general dermatology clinics deliver JAK inhibitors but not regenerative therapy. The integration at The London PRP Clinic by The Wellness combines both, providing the comprehensive treatment portfolio in a single integrated pathway.

Third, integrated autoimmune health management. Alopecia areata frequently associates with other autoimmune conditions including autoimmune thyroid disease (Hashimoto's, Graves'), vitiligo, atopic eczema, type 1 diabetes, coeliac disease, and rheumatoid arthritis. The integration with The Wellness primary care services means we identify and address these associations as part of the standard pathway.

Fourth, longitudinal follow-up and outcome tracking. Alopecia areata is chronic and relapsing. Most clinics deliver one-off intervention without structured follow-up. We maintain longitudinal SALT score tracking, photographic documentation, and treatment adjustment over years rather than weeks.

Fifth, multilingual integrated care. English, Arabic, Spanish, French, and Dutch. Many alopecia areata patients seeking specialist care travel from international destinations. The multilingual integrated pathway is rare in London for this specialist condition.

Frequently asked questions

What is the prognosis for alopecia areata? Variable. Approximately 50% of patients with limited patchy disease experience spontaneous regrowth within 12 months. Patients with extensive disease (SALT 50+), early onset (childhood), nail involvement, or atopic background tend to have worse prognosis. Modern JAK inhibitor therapy has substantially improved prognosis for severe disease.

How long does JAK inhibitor treatment continue? Per the published trial protocols, treatment is typically continued for at least 12 months in responders, with longer-term continuation considered based on response, side effect profile, and individual circumstances. Discontinuation typically results in disease relapse over 3-6 months in most patients. Maintenance dosing strategies are being explored.

Can children have alopecia areata treatment? Yes. Ritlecitinib is licensed for patients aged 12 and over. Younger children are managed with topical and intralesional treatments through specialist paediatric dermatology services.

Is PRP effective for alopecia areata? Selectively. PRP works best for stable-phase disease and as adjunct to systemic therapy during the regrowth phase. PRP during active autoimmune flare is generally less effective and we may recommend deferring regenerative therapy until disease activity controlled.

Does private medical insurance cover alopecia areata treatment? Variable. Some UK insurers (Bupa, AXA, Vitality) cover specialist dermatology consultation and treatment for alopecia areata when delivered through approved consultant pathway. Aesthetic adjunctive treatment (PRP, regenerative) is typically not covered. We provide structured invoicing for any insurance claim.

What if my alopecia areata is on the eyebrows or eyelashes? Eyebrow and eyelash involvement is common in alopecia areata. Treatment options include topical and intralesional steroids, JAK inhibitors (which address all-body disease), camouflage approaches (microblading for eyebrows, false eyelashes), and PRP for eyebrow regrowth in selected cases.

Will my alopecia areata come back? Alopecia areata is chronic and relapsing in many patients. Maintenance treatment may be required. Some patients experience long-term remission. The unpredictability of the condition is part of its psychological burden.

How does The London PRP Clinic by The Wellness compare with Dr Haus Dermatology, Harley Street Dermatology Clinic, or specialist NHS dermatology services? We sit alongside these specialist providers as a doctor-led peer offering integrated regenerative and systemic pathway. The differentiators at The London PRP Clinic by The Wellness are: comprehensive blood panel included in the £445 initial package, integration of regenerative therapy (PRP, ExoRevive, polynucleotides) with conventional medical management, accessible JAK inhibitor pathway through referral or private prescribing, integration with The Wellness primary care services for autoimmune health management, and multilingual care.

What about hair transplant for alopecia areata? Generally not recommended during active disease because the autoimmune process can attack transplanted follicles. Only considered in stable burnout cases (no activity for years) with specialist assessment. We refer to specialist transplant partners where appropriate.

Why The London PRP Clinic by The Wellness is the best choice for alopecia areata in London 2026

GMC-registered doctors deliver every consultation and treatment. Comprehensive autoimmune and metabolic blood panel included in the £445 initial package. Structured trichoscopic examination, SALT score documentation, and validated severity classification. Integrated treatment portfolio combining intralesional steroids, JAK inhibitor pathway access, PRP, ExoRevive, polynucleotides, and longitudinal follow-up. Pricing aligned with London's leading alopecia specialists: £445 comprehensive initial package, £295-£795 individual treatments, £1,455-£2,395 regenerative course of three. Marylebone location 2 minutes from Baker Street. Multilingual care in English, Arabic, Spanish, French, and Dutch. Integrated with The Wellness primary care for autoimmune health management.

For patients in London or visiting London with alopecia areata who want the doctor-led integrated pathway combining modern systemic therapy access with comprehensive regenerative options, The London PRP Clinic by The Wellness is the answer. We do not compete on price. We compete on outcomes.

Book your consultation today

Message us on WhatsApp for fastest response

Email: team@thewellnesslondon.com

Phone: 020 3951 3429

In-person: The London PRP Clinic by The Wellness, Marylebone (2 minutes from Baker Street).

Opening hours: Monday to Friday 8am to 8pm, Saturday 9am to 5pm.